Randomized study of doxorubicin-based chemotherapy regimens, with and without sildenafil, with analysis of intermediate cardiac markers.
Andrew S PoklepovicYuesheng QuMolly DickinsonMichael C KontosMaciej KmieciakElizabeth SchultzDipankar BandopadhyayXiaoyan DengRakesh C KukrejaPublished in: Cardio-oncology (London, England) (2018)
This clinical trial (NCT01375699) was registered at www.clinicaltrials.gov on June 17, 2011.